{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:58Z","timestamp":1791261178324,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jaacap.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaac.2019.03.019","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:49:36Z","timestamp":1553726976000},"page":"1051-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Making Use of What We Know: Medical Decision-Making and Antipsychotics"],"prefix":"10.1016","volume":"58","author":[{"given":"Gail A.","family":"Edelsohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2019.03.019_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","article-title":"Comprehensive versus usual community care for first episode psychosis: two-year outcomes from the NIMH RAISE early treatment program","volume":"173","author":"Kane","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized placebo-controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jaac.2019.01.015","volume":"58","author":"Jensen","year":"2019","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaac.2016.12.013","article-title":"Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis","volume":"56","author":"Pagsberg","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamapsychiatry.2018.1088","article-title":"Metabolic effects of antipsychotics on adiposity and insulin sensitivity in youths: a randomized clinical trial","volume":"75","author":"Nicol","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamapsychiatry.2018.3421","article-title":"Association of antipsychotic treatment with risk of unexpected death among children and youths","volume":"76","author":"Ray","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","article-title":"Treatment of young people with antipsychotics in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2019.03.019_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0000000000003784","article-title":"National trends in off-label use of atypical antipsychotics in children and adolescents in the United States","volume":"95","author":"Sohn","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jaac.2019.03.019_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaac.2019.03.019_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00148581-200406010-00003","article-title":"Weight again associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management","volume":"6","author":"Stigler","year":"2004","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.jaac.2019.03.019_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.2014-2260","article-title":"Antipsychotic prescribing in children enrolled in Medicaid","volume":"135","author":"Rettew","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2019.03.019_bib12","first-page":"238","article-title":"Differences in Medicaid antipsychotic measures among children with SSI, foster care, and income-based aid","volume":"24","author":"Leckman-Westin","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719302138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856719302138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:20:27Z","timestamp":1571804427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856719302138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0890856719302138"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2019.03.019","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Making Use of What We Know: Medical Decision-Making and Antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.01.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}